Skip to content

13F-HR filed by Alden Global Capital LLC

Alden Global Capital LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 12 holding rows worth $292,651,000.

Accession
0001616882-17-000001
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 12 entries on the cover page, a total value of $292,651,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $292,651,000 with VALUE read as thousands by filing date, 13F file number 028-16914. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
FRED S INC CLASS A356108100COM9,275,000$172,144,000thousands by filing date
PIER 1 IMPORTS INC720279108COM7,632,034$65,178,000thousands by filing date
OCTAVE SPECIALTY GROUP INC023139884COM NEW1,735,150$39,040,000thousands by filing date
INTERNATIONAL SEAWAYS INC COMY41053102Stock360,334$5,060,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock61,287$1,980,000thousands by filing date
MECHEL PAO583840608SPONSORED ADR NE342,805$1,964,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock56,900$1,883,000thousands by filing date
CIA ENERGETICA DE MINAS GERA204409601SP ADR N-V PFD781,000$1,780,000thousands by filing date
ParkerVision Inc701354300USD592,633$1,091,000thousands by filing date
HERON THERAPEUTICS INC427746102COM65,935$864,000thousands by filing date
ACCELERON PHARMA INC00434H108COM33,700$860,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK640,500$807,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001616882-17-000001this filing2017-02-14acceptance time not in the bulk data set